ACLYの抑制は腫瘍免疫を促進し,肝がんを抑制する
Jaya Gautam1,2, Jianhan Wu1,2, James S V Lally1,2
1Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Nature
|July 31, 2025
まとめ
メタボリック機能障害に関連した脂肪肝炎 (MASH) 誘発性肝がん (HCC) の治療において,ATPシトラートライアス (ACLY) をEVT0185で標的化することで,腫瘍負荷が軽減されます. このアプローチは 免疫マイクロ環境を再構成し 抗がん免疫を強化し 標準的な治療への反応を改善します
科学分野:
- 腫瘍学
- 代謝 疾患
- 免疫学
背景:
- メタボリック機能障害に関連したステアトヘパチス (MASH) 誘発性肝細胞癌 (HCC) は,しばしば免疫抑制性腫瘍の微環境を特徴とする.
- 免疫細胞の代謝がエフェクタ機能に果たす役割は知られているが,腫瘍代謝ががんの免疫性に影響する事は完全に理解されていない.
- 細胞代謝を脂質生物合成と遺伝子調節に結びつける重要な酵素であり,その抑制は抗癌の可能性を示しているが,臨床翻訳の課題に直面している.
研究 の 目的:
- MASH駆動のHCCにおけるATPシトラートライアス (ACLY) を標的とする治療の可能性を調査する.
- MASH- HCC治療のための新しい小分子ACLY阻害剤を特定し,特徴づけること.
- ACLYの抑制が腫瘍の免疫微環境と抗腫瘍反応に影響するメカニズムを解明する.
主な方法:
- ヒトの病気を再現するマウスモデルを活用しました
- 遺伝的に抑制されたACLYは肝細胞と腫瘍に
- 小分子ACLY阻害剤EVT0185をフェノタイプスクリーニングで特定し,その作用メカニズムを冷凍電子顕微鏡で明らかにした.
- 3つのMASH- HCCマウスモデルで,単体療法と標準治療との併用の両方で,EVT0185を経口投与した.
- マウスとヒトのサンプルでトランスクリプトミカルと空間的なプロファイリングを行いました.
- ACLY抑制の抗腫瘍効果を媒介するB細胞の役割を,B細胞枯渇研究を通じて調査した.
主要な成果:
- MASH- HCCマウスモデルにおけるACLYの遺伝的阻害は,腫瘍病変を70%以上減少させた.
- EVT0185の経口投与は,3つのMASH- HCCマウスモデルで単独療法として腫瘍負担を大幅に軽減し,チロシンキナーゼ阻害剤と免疫療法の有効性を高めました.
- 腫瘍ACLY値の低下は,CXCL13キモカイン,腫瘍に浸透するB細胞,および三次リンパ性構造の増加と関連していました.
- B細胞の枯渇はACLY抑制の抗腫瘍効果を無効にし,その重要な役割を強調した.
結論:
- ACLY抑制による腫瘍代謝を標的とした治療は,MASH- HCCにおけるがんの進行を効果的に抑制することができます.
- ACLY阻害は腫瘍の免疫微環境を再構成し,B細胞の浸透とリンパ性構造の形成によって特徴づけられる抗腫瘍免疫反応を促進します.
- 新型ACLY阻害剤EVT0185は,MASH- HCCにおいて,単独でも,既存の治療法と併用しても,腫瘍免疫を調節することによって,重要な治療の可能性を示しています.
さらに関連する動画
08:25Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
302
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
関連する概念動画
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
01:12Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K